Best Peptides for Anti-Aging: Research and Evidence

Aging is driven by several interconnected biological processes: telomere shortening, mitochondrial dysfunction, cellular senescence, declining hormone levels, and accumulated oxidative damage. Anti-aging peptides target these specific mechanisms rather than treating aging as a single condition. This guide covers the most researched peptides in the longevity space, what the evidence actually shows, and what remains theoretical.

Epithalon is a synthetic tetrapeptide (Ala-Glu-Asp-Gly) that targets telomere maintenance. It works by activating telomerase, the enzyme that maintains telomere length at the ends of chromosomes. Telomere shortening is one of the hallmarks of cellular aging — when telomeres get too short, cells stop dividing and become senescent.

Research from Russian institutions has shown that Epithalon can increase telomerase activity, restore melatonin production in aging pineal glands, and extend lifespan in animal models. It is typically administered as 5-10 mg subcutaneously daily for 10-20 day courses, repeated 2-3 times per year.

The main concern is theoretical: activating telomerase could also benefit pre-cancerous cells. Western clinical data remains limited, with most evidence coming from Russian studies.

GHK-Cu is a naturally occurring tripeptide (Gly-His-Lys) bound to a copper ion. It declines significantly with age — blood levels at age 60 are roughly 40% of levels at age 20. This decline correlates with reduced wound healing capacity, thinning skin, and loss of collagen.

GHK-Cu works by activating over 4,000 genes involved in tissue remodeling, including genes for collagen production, antioxidant enzymes, and DNA repair. It is available as topical serums (most common and safest), injectable formulations, and microneedling applications.

Of all the anti-aging peptides, GHK-Cu has some of the strongest evidence for skin rejuvenation specifically. Multiple studies show improvements in skin elasticity, wrinkle depth, and collagen density with topical application.

SS-31 targets the mitochondria — the energy-producing organelles that become dysfunctional with age. It is a tetrapeptide that concentrates in the inner mitochondrial membrane, specifically binding to cardiolipin, a lipid critical for electron transport chain function.

By stabilizing cardiolipin, SS-31 restores mitochondrial efficiency, reduces reactive oxygen species production, and improves cellular energy output. This is significant because mitochondrial dysfunction is considered one of the primary drivers of age-related decline affecting every organ system.

SS-31 has been studied in clinical trials for heart failure, Barth syndrome, and age-related mitochondrial diseases. It is administered via subcutaneous or intravenous injection. Results in Barth syndrome have been promising, though heart failure trials have shown mixed results.

NAD+ (nicotinamide adenine dinucleotide) is a coenzyme essential for cellular energy production, DNA repair, and sirtuin enzyme activity. NAD+ levels decline approximately 50% between ages 40 and 60, contributing to metabolic dysfunction, neurodegeneration, and impaired DNA repair.

Direct NAD+ supplementation via IV infusion (250-1000 mg per session) provides immediate restoration of cellular NAD+ pools. Oral precursors like NMN (nicotinamide mononucleotide) and NR (nicotinamide riboside) at 250-1000 mg daily offer a more convenient but less direct approach.

The theoretical concern with NAD+ is that cancer cells also have high energy demands, so boosting NAD+ could potentially fuel existing tumors. Most research supports the safety of oral precursors at standard doses, while IV protocols require monitoring.

Humanin is a 24-amino-acid mitochondrial-derived peptide that declines with age. It has broad protective effects: it shields neurons from amyloid-beta toxicity (relevant to Alzheimer's), protects cardiac cells from stress, and improves insulin sensitivity.

Humanin is still primarily a research compound with limited human clinical data. The main safety concern is that it may protect cancer cells from programmed death through its interaction with the BAX protein. Dosing is not standardized, with most protocols using 1-5 mg subcutaneously daily.

For skin aging specifically: GHK-Cu has the most practical evidence, especially in topical form. It is the safest starting point and the most accessible.

For cellular energy and mitochondrial health: SS-31 or NAD+ supplementation address the energy decline that underlies much of aging.

For telomere maintenance: Epithalon is the primary option, though the evidence base is limited to Russian studies.

For neuroprotection: Humanin shows promise for brain aging but remains experimental.

A comprehensive anti-aging approach would target multiple mechanisms simultaneously. However, the more compounds involved, the greater the unknowns about interactions and long-term safety. Starting with one well-characterized compound and monitoring results is the prudent approach. All of these are research compounds except where noted — consult a healthcare professional.